LOC339290 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.510800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.240000E-01
Normal-vs-Stage2
3.910800E-01
Normal-vs-Stage3
9.770300E-02
Normal-vs-Stage4
9.949800E-01
Stage1-vs-Stage2
2.587000E-01
Stage1-vs-Stage3
1.055600E-01
Stage1-vs-Stage4
7.120400E-01
Stage2-vs-Stage3
1.219440E-01
Stage2-vs-Stage4
3.224200E-01
Stage3-vs-Stage4
1.476810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.888600E-01
Normal-vs-AfricanAmerican
4.321800E-01
Normal-vs-Asian
2.462600E-01
Caucasian-vs-AfricanAmerican
7.227000E-01
Caucasian-vs-Asian
2.826800E-01
AfricanAmerican-vs-Asian
5.982600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.656400E-01
Normal-vs-Female
8.336600E-01
Male-vs-Female
1.408610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.654200E-01
Normal-vs-Age(41-60Yrs)
9.971000E-01
Normal-vs-Age(61-80Yrs)
4.656400E-01
Normal-vs-Age(81-100Yrs)
1.447220E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.241600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.865800E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.572200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.816260E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.010140E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.341600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.611600E-01
Normal-vs-Daily Drinker
3.828400E-01
Normal-vs-Weekly Drinker
7.460800E-01
Normal-vs-Occasional Drinker
9.711800E-01
Normal-vs-Social Drinker
8.219600E-01
Non Drinker-vs-Daily Drinker
8.664000E-01
Non Drinker-vs-Weekly Drinker
2.783600E-01
Non Drinker-vs-Occasional Drinker
1.852590E-01
Non Drinker-vs-Social Drinker
1.354990E-01
Daily Drinker-vs-Weekly Drinker
3.100400E-01
Daily Drinker-vs-Occasional Drinker
1.855220E-01
Daily Drinker-vs-Social Drinker
1.379250E-01
Weekly Drinker-vs-Occasional Drinker
7.085000E-01
Weekly Drinker-vs-Social Drinker
4.138000E-01
Occasional Drinker-vs-Social Drinker
6.218200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.577200E-01
Normal-vs-Grade 2
8.887200E-01
Normal-vs-Grade 3
9.103400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.262410E-01
Grade 1-vs-Grade 3
1.023990E-01
Grade 1-vs-Grade 4
5.577200E-01
Grade 2-vs-Grade 3
7.069400E-01
Grade 2-vs-Grade 4
8.887200E-01
Grade 3-vs-Grade 4
9.103400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.708360E-01
Normal-vs-NonDiabetic
7.502200E-01
Diabetic-vs-NonDiabetic
1.454220E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.861000E-01
Normal-vs-NoPancreatitis
6.102200E-01
Pancreatitis-vs-NoPancreatitis
9.848000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.275000E-01
Normal-vs-N1
4.040000E-01
N0-vs-N1
1.566030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.165000E-01
Normal-vs-TP53-NonMutant
9.044800E-01
TP53-Mutant-vs-TP53-NonMutant
5.295600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
